MRD evaluation of AML in clinical practice: are we there yet?

od Freeman, Sylvie D., Hourigan, Christopher S.
izdano v Hematology Am Soc Hematol Educ Program (2019)

Evaluating measurable residual disease in acute myeloid leukemia

od Ravandi, Farhad, Walter, Roland B., Freeman, Sylvie D.
izdano v Blood Adv (2018)

Role of Minimal (Measurable) Residual Disease Assessment in Older Patients with Acute Myeloid Leukemia

od Buccisano, Francesco, Dillon, Richard, Freeman, Sylvie D., Venditti, Adriano
izdano v Cancers (Basel) (2018)

Reduced CD38 expression on CD34(+) cells as a diagnostic test in myelodysplastic syndromes

od Goardon, Nicolas, Nikolousis, Emmanouil, Sternberg, Alexander, Chu, Wai-Kit, Craddock, Charles, Richardson, Peter, Benson, Richard, Drayson, Mark, Standen, Graham, Vyas, Paresh, Freeman, Sylvie
Izdano 2009

Expression of CD33 is a predictive factor for effect of Gemtuzumab Ozogamicin at different doses in adult acute myeloid leukemia

od Khan, Naeem, Hills, Robert K, Virgo, Paul, Couzens, Stephen, Clark, Nithiya, Gilkes, Amanda, Richardson, Peter, Knapper, Steven, Grimwade, David, Russell, Nigel H, Burnett, Alan K, Freeman, Sylvie D
izdano v Leukemia (2016)

Normal Hematopoietic Progenitor Subsets Have Distinct Reactive Oxygen Species, BCL2 and Cell-Cycle Profiles That Are Decoupled from Maturation in Acute Myeloid Leukemia

od Khan, Naeem, Hills, Robert K., Knapper, Steve, Steadman, Lora, Qureshi, Ushna, Rector, Jerrald L., Bradbury, Charlotte, Russell, Nigel H., Vyas, Paresh, Burnett, Alan K., Grimwade, David, Hole, Paul S., Freeman, Sylvie D.
izdano v PLoS One (2016)

Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia: A Systematic Review and Meta-analysis

od Short, Nicholas J., Zhou, Shouhao, Fu, Chenqi, Berry, Donald A., Walter, Roland B., Freeman, Sylvie D., Hourigan, Christopher S., Huang, Xuelin, Nogueras Gonzalez, Graciela, Hwang, Hyunsoo, Qi, Xinyue, Kantarjian, Hagop, Ravandi, Farhad
izdano v JAMA Oncol (2020)

A Novel Role for PECAM-1 (CD31) in Regulating Haematopoietic Progenitor Cell Compartmentalization between the Peripheral Blood and Bone Marrow

od Ross, Ewan A., Freeman, Sylvie, Zhao, Yan, Dhanjal, Tarvinder S., Ross, Emma J., Lax, Sian, Ahmed, Zubair, Hou, Tie Zheng, Kalia, Neena, Egginton, Stuart, Nash, Gerard, Watson, Steve P., Frampton, Jon, Buckley, Christopher D.
Izdano 2008

Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses

od Burnett, Alan K., Russell, Nigel H., Hills, Robert K., Knapper, Stephen, Freeman, Sylvie, Huntly, Brian, Clark, Richard E., Thomas, Ian F., Kjeldsen, Lars, McMullin, Mary Frances, Drummond, Mark, Kell, Jonathan, Spearing, Ruth
izdano v J Clin Oncol (2021)

Prognostic value of monitoring a candidate immunophenotypic leukemic stem/progenitor cell population in patients allografted for acute myeloid leukemia

od Bradbury, Charlotte, Houlton, Aimee E, Akiki, Susanna, Gregg, Richard, Rindl, Max, Khan, Josephine, Ward, Janice, Khan, Naeem, Griffiths, Mike, Nagra, Sandeep, Hills, Robert, Burnett, Alan, Russell, Nigel, Vyas, Paresh, Grimwade, David, Craddock, Charles, Freeman, Sylvie D.
izdano v Leukemia (2014)

Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study

od Della Porta, Matteo G., Picone, Cristina, Pascutto, Cristiana, Malcovati, Luca, Tamura, Hideto, Handa, Hiroshi, Czader, Magdalena, Freeman, Sylvie, Vyas, Paresh, Porwit, Anna, Saft, Leonie, Westers, Theresia M., Alhan, Canan, Cali, Claudia, van de Loosdrecht, Arjan A., Ogata, Kiyoyuki
Izdano 2012

Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations

od Freeman, Sylvie D., Hills, Robert K., Virgo, Paul, Khan, Naeem, Couzens, Steve, Dillon, Richard, Gilkes, Amanda, Upton, Laura, Nielsen, Ove Juul, Cavenagh, James D., Jones, Gail, Khwaja, Asim, Cahalin, Paul, Thomas, Ian, Grimwade, David, Burnett, Alan K., Russell, Nigel H.
izdano v J Clin Oncol (2018)

Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia

od Milne, Paul, Wilhelm-Benartzi, Charlotte, Grunwald, Michael R., Bigley, Venetia, Dillon, Richard, Freeman, Sylvie D., Gallagher, Kathleen, Publicover, Amy, Pagan, Sarah, Marr, Helen, Jones, Gail L., Dickinson, Anne M., Grech, Angela, Burnett, Alan K., Russell, Nigel H., Levis, Mark, Knapper, Steven, Collin, Matthew
izdano v Blood Adv (2019)

Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML

od Basheer, Faisal, Giotopoulos, George, Meduri, Eshwar, Yun, Haiyang, Mazan, Milena, Sasca, Daniel, Gallipoli, Paolo, Marando, Ludovica, Gozdecka, Malgorzata, Asby, Ryan, Sheppard, Olivia, Dudek, Monika, Bullinger, Lars, Döhner, Hartmut, Dillon, Richard, Freeman, Sylvie, Ottmann, Oliver, Burnett, Alan, Russell, Nigel, Papaemmanuil, Elli, Hills, Robert, Campbell, Peter, Vassiliou, George S., Huntly, Brian J.P.
izdano v J Exp Med (2019)

MHC class-I associated phosphopeptides are the targets of memory-like immunity in leukemia

od Cobbold, Mark, De La Peña, Hugo, Norris, Andrew, Polefrone, Joy, Qian, Jie, English, A. Michelle, Cummings, Kara, Penny, Sarah, Turner, James E., Cottine, Jennifer, Abelin, Jennifer G, Malaker, Stacy A, Zarling, Angela L, Huang, Hsing-Wen, Goodyear, Oliver, Freeman, Sylvie, Shabanowitz, Jeffrey, Pratt, Guy, Craddock, Charles, Williams, Michael E, Hunt, Donald F, Engelhard, Victor H
Izdano 2013

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

od Schuurhuis, Gerrit J., Heuser, Michael, Freeman, Sylvie, Béné, Marie-Christine, Buccisano, Francesco, Cloos, Jacqueline, Grimwade, David, Haferlach, Torsten, Hills, Robert K., Hourigan, Christopher S., Jorgensen, Jeffrey L., Kern, Wolfgang, Lacombe, Francis, Maurillo, Luca, Preudhomme, Claude, van der Reijden, Bert A., Thiede, Christian, Venditti, Adriano, Vyas, Paresh, Wood, Brent L., Walter, Roland B., Döhner, Konstanze, Roboz, Gail J., Ossenkoppele, Gert J.
izdano v Blood (2018)

Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia

od Craddock, Charles, Jackson, Aimee, Loke, Justin, Siddique, Shamyla, Hodgkinson, Andrea, Mason, John, Andrew, Georgia, Nagra, Sandeep, Malladi, Ram, Peniket, Andrew, Gilleece, Maria, Salim, Rahuman, Tholouli, Eleni, Potter, Victoria, Crawley, Charles, Wheatley, Keith, Protheroe, Rachel, Vyas, Paresh, Hunter, Ann, Parker, Anne, Wilson, Keith, Pavlu, Jiri, Byrne, Jenny, Dillon, Richard, Khan, Naeem, McCarthy, Nicholas, Freeman, Sylvie D.
izdano v J Clin Oncol (2021)

Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi‐centre setting

od Hanekamp, Diana, Snel, Alexander N., Kelder, Angèle, Scholten, Willemijn J., Khan, Naeem, Metzner, Marlen, Irno‐Consalvo, Maria, Sugita, Mayumi, de Jong, Anja, Oude Alink, Sjoerd, Eidhof, Harrie, Wilhelm, Miriam, Feuring‐Buske, Michaela, Slomp, Jennichjen, van der Velden, Vincent H. J., Sonneveld, Edwin, Guzman, Monica, Roboz, Gail J., Buccisano, Francesco, Vyas, Paresh, Freeman, Sylvie, Bachas, Costa, Ossenkoppele, Gert J., Schuurhuis, Gerrit J., Cloos, Jacqueline
izdano v Br J Haematol (2020)

Genetically distinct leukemic stem cells in human CD34(−) acute myeloid leukemia are arrested at a hemopoietic precursor-like stage

od Quek, Lynn, Otto, Georg W., Garnett, Catherine, Lhermitte, Ludovic, Karamitros, Dimitris, Stoilova, Bilyana, Lau, I-Jun, Doondeea, Jessica, Usukhbayar, Batchimeg, Kennedy, Alison, Metzner, Marlen, Goardon, Nicolas, Ivey, Adam, Allen, Christopher, Gale, Rosemary, Davies, Benjamin, Sternberg, Alexander, Killick, Sally, Hunter, Hannah, Cahalin, Paul, Price, Andrew, Carr, Andrew, Griffiths, Mike, Virgo, Paul, Mackinnon, Stephen, Grimwade, David, Freeman, Sylvie, Russell, Nigel, Craddock, Charles, Mead, Adam, Peniket, Andrew, Porcher, Catherine, Vyas, Paresh
izdano v J Exp Med (2016)

Molecular MRD status and outcome after transplantation in NPM1-mutated AML

od Dillon, Richard, Hills, Robert, Freeman, Sylvie, Potter, Nicola, Jovanovic, Jelena, Ivey, Adam, Kanda, Anju Shankar, Runglall, Manohursingh, Foot, Nicola, Valganon, Mikel, Khwaja, Asim, Cavenagh, Jamie, Smith, Matthew, Ommen, Hans Beier, Overgaard, Ulrik Malthe, Dennis, Mike, Knapper, Steven, Kaur, Harpreet, Taussig, David, Mehta, Priyanka, Raj, Kavita, Novitzky-Basso, Igor, Nikolousis, Emmanouil, Danby, Robert, Krishnamurthy, Pramila, Hill, Kate, Finnegan, Damian, Alimam, Samah, Hurst, Erin, Johnson, Peter, Khan, Anjum, Salim, Rahuman, Craddock, Charles, Spearing, Ruth, Gilkes, Amanda, Gale, Rosemary, Burnett, Alan, Russell, Nigel H., Grimwade, David
izdano v Blood (2020)